These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 327247)
1. Deapril-ST for senile dementia. Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247 [No Abstract] [Full Text] [Related]
2. Review of clinical studies with ergots in gerontology. Venn RD Adv Biochem Psychopharmacol; 1980; 23():363-77. PubMed ID: 7395623 [No Abstract] [Full Text] [Related]
3. Relieving select symptoms of the elderly. Nelson JJ Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912 [No Abstract] [Full Text] [Related]
4. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy]. Ronge J; Dennler HJ Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638 [No Abstract] [Full Text] [Related]
5. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency]. Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035 [No Abstract] [Full Text] [Related]
7. Pharmacotherapy of senile dementia. Reisberg B; Ferris SH; Gershon S Proc Annu Meet Am Psychopathol Assoc; 1980; 69():233-64. PubMed ID: 6997869 [No Abstract] [Full Text] [Related]
8. Controlled study of dihydroergotoxine in gerontopsychiatric patients. Slánská J Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002 [No Abstract] [Full Text] [Related]
10. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales. Yesavage JA; Adey M Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622 [No Abstract] [Full Text] [Related]
11. [The action of dihydroergotoxine in acute sickling crisis. Results of a double-blind study carried out in French speaking Africa (author's transl)]. Begue P; Bertrand E; Bonhomme J; David M; Coullet Y; Pierredon M; Sankale M Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2449-52. PubMed ID: 358140 [TBL] [Abstract][Full Text] [Related]
12. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report. Yesavage JA; Hollister LE; Burian E J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369 [TBL] [Abstract][Full Text] [Related]
13. Dihydroergocryptine in the management of senile psycho-organic syndrome. Scarzella L; Bono G; Bergamasco B Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697 [TBL] [Abstract][Full Text] [Related]
14. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult]. Dartigues JF; Père JJ Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936 [TBL] [Abstract][Full Text] [Related]
15. Drugs in geropsychiatry. Petrie WM; Ban TA Psychopharmacol Bull; 1978 Oct; 14(4):7-19. PubMed ID: 360264 [No Abstract] [Full Text] [Related]
16. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics]. Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587 [No Abstract] [Full Text] [Related]
17. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons]. Bagatin J; Rumboldt Z; Jurisić M; Vujić D Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457 [No Abstract] [Full Text] [Related]
18. Effects of naloxone in senile dementia: a double-blind trial. Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389 [No Abstract] [Full Text] [Related]
19. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia. Branconnier RJ Psychopharmacol Bull; 1983; 19(2):212-9. PubMed ID: 6408682 [No Abstract] [Full Text] [Related]
20. The clinical assessment of brain failure in the elderly. McConnachie RW Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]